297 related articles for article (PubMed ID: 26880578)
1. Antibodies against a secreted product of Staphylococcus aureus trigger phagocytic killing.
Thomer L; Emolo C; Thammavongsa V; Kim HK; McAdow ME; Yu W; Kieffer M; Schneewind O; Missiakas D
J Exp Med; 2016 Mar; 213(3):293-301. PubMed ID: 26880578
[TBL] [Abstract][Full Text] [Related]
2. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
Tkaczyk C; Hamilton MM; Sadowska A; Shi Y; Chang CS; Chowdhury P; Buonapane R; Xiao X; Warrener P; Mediavilla J; Kreiswirth B; Suzich J; Stover CK; Sellman BR
mBio; 2016 Jun; 7(3):. PubMed ID: 27353753
[TBL] [Abstract][Full Text] [Related]
3. Targeting the R domain of coagulase by active vaccination protects mice against lethal Staphylococcus aureus infection.
Qian M; Zhao T; Li R; Yang Q; Yu R; Yin Y; Zai X; Li Y; Zhang J; Xu J; Chen W
Microbes Infect; 2019; 21(3-4):163-169. PubMed ID: 30447395
[TBL] [Abstract][Full Text] [Related]
4. Coagulases as determinants of protective immune responses against Staphylococcus aureus.
McAdow M; DeDent AC; Emolo C; Cheng AG; Kreiswirth BN; Missiakas DM; Schneewind O
Infect Immun; 2012 Oct; 80(10):3389-98. PubMed ID: 22825443
[TBL] [Abstract][Full Text] [Related]
5. Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach.
Tkaczyk C; Kasturirangan S; Minola A; Jones-Nelson O; Gunter V; Shi YY; Rosenthal K; Aleti V; Semenova E; Warrener P; Tabor D; Stover CK; Corti D; Rainey G; Sellman BR
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584141
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB
PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
[TBL] [Abstract][Full Text] [Related]
7. Glycosylation-dependent opsonophagocytic activity of staphylococcal protein A antibodies.
Chen X; Shi M; Tong X; Kim HK; Wang LX; Schneewind O; Missiakas D
Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22992-23000. PubMed ID: 32855300
[TBL] [Abstract][Full Text] [Related]
8. N-acetylglucosaminylation of serine-aspartate repeat proteins promotes Staphylococcus aureus bloodstream infection.
Thomer L; Becker S; Emolo C; Quach A; Kim HK; Rauch S; Anderson M; Leblanc JF; Schneewind O; Faull KF; Missiakas D
J Biol Chem; 2014 Feb; 289(6):3478-86. PubMed ID: 24344128
[TBL] [Abstract][Full Text] [Related]
9. A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo.
Ebert T; Smith S; Pancari G; Clark D; Hampton R; Secore S; Towne V; Fan H; Wang XM; Wu X; Ernst R; Harvey BR; Finnefrock AC; Wang F; Tan C; Durr E; Cope L; Anderson A; An Z; McNeely T
Hum Antibodies; 2010; 19(4):113-28. PubMed ID: 21178283
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal Antibody Targeting Staphylococcus aureus Surface Protein A (SasA) Protect Against Staphylococcus aureus Sepsis and Peritonitis in Mice.
Yang Y; Qian M; Yi S; Liu S; Li B; Yu R; Guo Q; Zhang X; Yu C; Li J; Xu J; Chen W
PLoS One; 2016; 11(2):e0149460. PubMed ID: 26926145
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A.
Hall AE; Domanski PJ; Patel PR; Vernachio JH; Syribeys PJ; Gorovits EL; Johnson MA; Ross JM; Hutchins JT; Patti JM
Infect Immun; 2003 Dec; 71(12):6864-70. PubMed ID: 14638774
[TBL] [Abstract][Full Text] [Related]
12. The Staphylococcus aureus polysaccharide capsule and Efb-dependent fibrinogen shield act in concert to protect against phagocytosis.
Kuipers A; Stapels DAC; Weerwind LT; Ko YP; Ruyken M; Lee JC; van Kessel KPM; Rooijakkers SHM
Microbiology (Reading); 2016 Jul; 162(7):1185-1194. PubMed ID: 27112346
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to coagulase of
Bertoglio F; Ko YP; Thomas S; Giordano L; Scommegna FR; Meier D; Polten S; Becker M; Arora S; Hust M; Höök M; Visai L
Front Immunol; 2023; 14():1221108. PubMed ID: 37828992
[No Abstract] [Full Text] [Related]
14. Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo.
Liu B; Park S; Thompson CD; Li X; Lee JC
Virulence; 2017 Aug; 8(6):859-874. PubMed ID: 27936346
[TBL] [Abstract][Full Text] [Related]
15. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.
Maira-Litrán T; Kropec A; Goldmann DA; Pier GB
Infect Immun; 2005 Oct; 73(10):6752-62. PubMed ID: 16177353
[TBL] [Abstract][Full Text] [Related]
16. Immunisation With Immunodominant Linear B Cell Epitopes Vaccine of Manganese Transport Protein C Confers Protection against Staphylococcus aureus Infection.
Yang HJ; Zhang JY; Wei C; Yang LY; Zuo QF; Zhuang Y; Feng YJ; Srinivas S; Zeng H; Zou QM
PLoS One; 2016; 11(2):e0149638. PubMed ID: 26895191
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection.
Scully IL; Timofeyeva Y; Keeney D; Matsuka YV; Severina E; McNeil LK; Nanra J; Hu G; Liberator PA; Jansen KU; Anderson AS
Vaccine; 2015 Oct; 33(41):5452-5457. PubMed ID: 26319743
[TBL] [Abstract][Full Text] [Related]
18. Coagulase and Efb of Staphylococcus aureus Have a Common Fibrinogen Binding Motif.
Ko YP; Kang M; Ganesh VK; Ravirajan D; Li B; Höök M
mBio; 2016 Jan; 7(1):e01885-15. PubMed ID: 26733070
[TBL] [Abstract][Full Text] [Related]
19. Protective opsonic activity of antibodies against fibronectin-binding proteins (FnBPs) of Staphylococcus aureus.
Rozalska B; Wadström T
Scand J Immunol; 1993 May; 37(5):575-80. PubMed ID: 8484103
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus aureus-induced clotting of plasma is an immune evasion mechanism for persistence within the fibrin network.
Loof TG; Goldmann O; Naudin C; Mörgelin M; Neumann Y; Pils MC; Foster SJ; Medina E; Herwald H
Microbiology (Reading); 2015 Mar; 161(Pt 3):621-627. PubMed ID: 25533444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
